Alphabet's life science subsidiary Verily announced a strategic restructuring last year, shifting its focus to using AI and data science to improve precision health options. Andrew Trister, chief ...
In January 2023, Verily Life Sciences began to pull back from the many different areas of the healthcare sector in which it once played to better tailor its bets on becoming a more profitable company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback